{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T03:52:15Z","timestamp":1769053935112,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T00:00:00Z","timestamp":1578441600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Despite recent improvement in management, infective endocarditis (IE) continues to be associated with considerable risk of morbidity and mortality. Early identification of predictors of inpatient mortality is key in improving patient outcomes in IE. The aim of our study was to evaluate the role of serum troponin levels measurements as a marker of increased mortality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>A case-control study included adult patients with IE admitted to a tertiary care hospital in east Tennessee between December 2012 and July 2017. Cases were defined as patients with definitive IE who died in-hospital; controls were patients who did not die in hospital. First patient admission was included only. Data collected included the patients\u2019 demographic and baseline clinical information, microbiological data, injection drug use status, elevated serum troponins levels.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>Two hundred eighty three patients with definitive IE were included; median (IQR) age was 41 (30\u201357) years, and 153 (54%) patients were men. One-hundred sixty-four (58%) were injection drug users. The most frequent IE type was: 167 (59%) right-sided, 86 (30%) left-sided, 24 (9%) both left and right-sided, and 10 (4%) device related. The most commonly isolated organism was <jats:italic>Staphylococcus aureus<\/jats:italic> (<jats:italic>n<\/jats:italic>\u00a0=\u2009141), and 64% were methicillin-resistant. Two-hundred twelve (75%) patients had a troponin level obtained, and 57 (27%) had an elevated troponin value. Thirty-six (13%) patients died in-hospital; in-hospital mortality was associated elevated troponin values (adjusted odds ratio [adjOR], 7.3; 95%CI, 3.3\u201315.9), and methicillin-resistant <jats:italic>S. aureus<\/jats:italic> IE (adjOR 2.6; 95%CI, 1.2\u20135.8). Forty-four (16%) patients received IE valve surgery, and none of these patients died in the hospital.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Inpatient mortality was higher in patients with IE and elevated cardiac troponin levels compared to patients with normal levels.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-019-4755-z","type":"journal-article","created":{"date-parts":[[2020,1,8]],"date-time":"2020-01-08T16:02:47Z","timestamp":1578499367000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Elevated troponin level as a predictor of inpatient mortality in patients with infective endocarditis in the Southeast United States"],"prefix":"10.1186","volume":"20","author":[{"given":"William","family":"Lorson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael P.","family":"Veve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Heidel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3371-5101","authenticated-orcid":false,"given":"Mahmoud A.","family":"Shorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,1,8]]},"reference":[{"issue":"9","key":"4755_CR1","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/j.cjca.2014.03.042","volume":"30","author":"F Thuny","year":"2014","unstructured":"Thuny F, Grisoli D, Cautela J, Riberi A, Raoult D, Habib G. Infective endocarditis: prevention, diagnosis, and management. Can J Cardiol. 2014;30(9):1046\u201357. https:\/\/doi.org\/10.1016\/j.cjca.2014.03.042.","journal-title":"Can J Cardiol"},{"issue":"2","key":"4755_CR2","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1590\/S0104-42302011000200023","volume":"57","author":"M Grinberg","year":"2011","unstructured":"Grinberg M, Solimene MC. Historical aspects of infective endocarditis. Revista da Associacao Medica Brasileira (1992). 2011;57(2):228\u201333 Published Online First:04\/05\/ 2011.","journal-title":"Revista da Associacao Medica Brasileira (1992)"},{"issue":"1","key":"4755_CR3","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.ahj.2012.04.003","volume":"164","author":"F Thuny","year":"2012","unstructured":"Thuny F, Giorgi R, Habachi R, et al. Excess mortality and morbidity in patients surviving infective endocarditis. Am Heart J. 2012;164(1):94\u2013101. https:\/\/doi.org\/10.1016\/j.ahj.2012.04.003.","journal-title":"Am Heart J"},{"issue":"5","key":"4755_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11908-017-0574-9","volume":"19","author":"J Ambrosioni","year":"2017","unstructured":"Ambrosioni J, Hernandez-Meneses M, T\u00e9llez A, Hospital Clinic Infective Endocarditis Investigators, et al. The changing epidemiology of infective endocarditis in the twenty-first century. Curr Infect Dis Rep. 2017;19(5):21. https:\/\/doi.org\/10.1007\/s11908-017-0574-9.","journal-title":"Curr Infect Dis Rep"},{"issue":"3","key":"4755_CR5","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","volume":"3","author":"AG Wurcel","year":"2016","unstructured":"Wurcel AG, Anderson JE, Chui KKH, Skinner S, Knox TA, Snydman DR, et al. Increasing infectious endocarditis admissions among young people who inject drugs. Open Forum Infect Dis. 2016;3(3):ofw157Published online 2016 Jul 26. https:\/\/doi.org\/10.1093\/ofid\/ofw157.","journal-title":"Open Forum Infect Dis"},{"key":"4755_CR6","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1093\/eurheartj\/ehp085","volume":"32","author":"RW Sy","year":"2011","unstructured":"Sy RW, Chawantanpipat C, Richmond DR, Kritharides L. Development and validation of a time-dependent risk model for predicting mortality in infective endocarditis. Eur Heart J. 2011;32:2016\u201326.","journal-title":"Eur Heart J"},{"key":"4755_CR7","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1001\/jama.289.15.1933","volume":"289","author":"R Hasbun","year":"2003","unstructured":"Hasbun R, Vikram HR, Barakat LA, Buenconsejo J, Quagliarello VJ. Complicated left-sided native valve endocarditis in adults: risk classification for mortality. JAMA. 2003;289:1933\u201340.","journal-title":"JAMA."},{"issue":"2","key":"4755_CR8","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1590\/S0102-76382007000200007","volume":"22","author":"MA Costa","year":"2007","unstructured":"Costa MA, Wollmann DR, Campos AC, et al. Risk index for death by infective endocarditis: a multivariate logistic model. Rev Bras Cir Cardiovasc. 2007;22(2):192\u2013200.","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"4755_CR9","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.ijid.2015.03.004","volume":"34","author":"E Gucuk Ipek","year":"2015","unstructured":"Gucuk Ipek E, Guray Y, Acar B, et al. The usefulness of serum troponin levels to predict 1-year survival rates in infective endocarditis. Int J Infect Dis. 2015;34:71\u20135. https:\/\/doi.org\/10.1016\/j.ijid.2015.03.004 published Online First: 07\/03\/2015.","journal-title":"Int J Infect Dis"},{"key":"4755_CR10","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ijcard.2016.07.130","volume":"222","author":"ZA Thoker","year":"2016","unstructured":"Thoker ZA, Khan KA, Rashid I, et al. Correlation of cardiac troponin I levels with infective endocarditis & its adverse clinical outcomes. Int J Cardiol. 2016;222:661\u20134. https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.130.","journal-title":"Int J Cardiol"},{"issue":"4","key":"4755_CR11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","volume":"30","author":"JS Li","year":"2000","unstructured":"Li JS, Sexton DJ, Mick N, Nettles R, Fowler VG Jr, Ryan T, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis. 2000;30(4):633\u20138. https:\/\/doi.org\/10.1086\/313753 PubMed PMID: 10770721.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"4755_CR12","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1016\/j.amjcard.2008.01.031","volume":"101","author":"JB Purcell","year":"2008","unstructured":"Purcell JB, Patel M, Khera A, et al. Relation of troponin elevation to outcome in patients with infective endocarditis. Am J Cardiol. 2008;101(10):1479\u201381. https:\/\/doi.org\/10.1016\/j.amjcard.2008.01.031 published Online First: 2008\/03\/17.","journal-title":"Am J Cardiol"},{"issue":"3","key":"4755_CR13","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000149573","volume":"112","author":"P Tsenovoy","year":"2009","unstructured":"Tsenovoy P, Aronow WS, Joseph J, et al. Patients with infective endocarditis and increased cardiac troponin I levels have a higher incidence of in-hospital mortality and valve replacement than those with normal cardiac troponin I levels. Cardiology. 2009;112(3):202\u20134. https:\/\/doi.org\/10.1159\/000149573 published Online First: 2008\/08\/01.","journal-title":"Cardiology"},{"issue":"3","key":"4755_CR14","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/j.amjcard.2011.03.061","volume":"108","author":"AB Stancoven","year":"2011","unstructured":"Stancoven AB, Shiue AB, Khera A, et al. Association of troponin T, detected with highly sensitive assay, and outcomes in infective endocarditis. Am J Cardiol. 2011;108(3):416\u201320. https:\/\/doi.org\/10.1016\/j.amjcard.2011.03.061.","journal-title":"Am J Cardiol"},{"issue":"7","key":"4755_CR15","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1136\/hrt.2005.071282","volume":"92","author":"S Korff","year":"2006","unstructured":"Korff S, Katus HA, Giannitsis E. Differential diagnosis of elevated troponins. Heart. 2006;92(7):987\u201393. https:\/\/doi.org\/10.1136\/hrt.2005.071282.","journal-title":"Heart"},{"issue":"4","key":"4755_CR16","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1111\/j.1523-1755.2004.00927.x","volume":"66","author":"RL Mehta","year":"2004","unstructured":"Mehta RL, Pascual MT, Soroko S, et al. Spectrum of acute renal failure in the intensive care unit: the PICARD experience. Kidney Int. 2004;66(4):1613\u201321. https:\/\/doi.org\/10.1111\/j.1523-1755.2004.00927.x.","journal-title":"Kidney Int"},{"issue":"1","key":"4755_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1136\/heart.88.1.53","volume":"88","author":"SM Wallace","year":"2002","unstructured":"Wallace SM, Walton BI, Kharbanda RK, et al. Mortality from infective endocarditis: clinical predictors of outcome. Heart. 2002;88(1):53\u201360.","journal-title":"Heart"},{"issue":"14","key":"4755_CR18","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1161\/01.CIR.0000124719.61827.7F","volume":"109","author":"VH Chu","year":"2004","unstructured":"Chu VH, Cabell CH, Benjamin DK, et al. Early predictors of in-hospital death in infective endocarditis. Circulation. 2004;109(14):1745\u20139. https:\/\/doi.org\/10.1161\/01.CIR.0000124719.61827.7F published Online First: 2004\/03\/22.","journal-title":"Circulation"},{"key":"4755_CR19","first-page":"e185220","volume":"1","author":"L Rodger","year":"2018","unstructured":"Rodger L, Glockler-Lauf SD, Shojaei E, et al. Clinical characteristics and factors associated with mortality in first-episode infective endocarditis among persons who inject drugs. JAMA. 2018;1:e185220.","journal-title":"JAMA"},{"issue":"9","key":"4755_CR20","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1093\/eurheartj\/ehm005","volume":"28","author":"F Thuny","year":"2007","unstructured":"Thuny F, Avierinos JF, Tribouilloy C, et al. Impact of cerebrovascular complications on mortality and neurologic outcome during infective endocarditis: a prospective multi Centre study. Eur Heart J. 2007;28(9):1155\u201361. https:\/\/doi.org\/10.1093\/eurheartj\/ehm005.","journal-title":"Eur Heart J"},{"issue":"3","key":"4755_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.amjcard.2015.11.012","volume":"117","author":"C Ferrera","year":"2016","unstructured":"Ferrera C, Vilacosta I, Fern\u00e1ndez C, L\u00f3pez J, Sarri\u00e1 C, Olmos C, et al. Usefulness of new-onset atrial fibrillation, as a strong predictor of heart failure and death in patients with native left-sided infective endocarditis. Am J Cardiol. 2016;117(3):427\u201333. https:\/\/doi.org\/10.1016\/j.amjcard.2015.11.012 Epub 2015 Nov 18.","journal-title":"Am J Cardiol"},{"issue":"5","key":"4755_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1136\/heart.89.5.577","volume":"89","author":"R Moss","year":"2003","unstructured":"Moss R, Munt B. Injection drug use and right sided endocarditis. Heart. 2003;89(5):577\u201381. https:\/\/doi.org\/10.1136\/heart.89.5.577.","journal-title":"Heart."},{"issue":"3","key":"4755_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/0885066614554906","volume":"31","author":"M Klein","year":"2016","unstructured":"Klein M, Wang A. Infective endocarditis. J Intensive Care Med. 2016;31(3):151\u201363. https:\/\/doi.org\/10.1177\/0885066614554906.","journal-title":"J Intensive Care Med"},{"issue":"3","key":"4755_CR24","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1007\/s15010-007-5125-0","volume":"35","author":"FG De Rosa","year":"2007","unstructured":"De Rosa FG, Cicalini S, Canta F, Audagnotto S, Cecchi E, Di Perri G. Infective endocarditis in intravenous drug users from Italy: the increasing importance in HIV-infected patients. Infection. 2007;35(3):154\u201360. https:\/\/doi.org\/10.1007\/s15010-007-5125-0.","journal-title":"Infection"},{"key":"4755_CR25","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.jacc.2018.10.082","volume":"73","author":"SE Rudasill","year":"2019","unstructured":"Rudasill SE, Sanaiha Y, Mardock AL, et al. Clinical outcomes of infective endocarditis in injection drug users. J Am Coll Cardiol. 2019;73:559\u201370.","journal-title":"J Am Coll Cardiol"},{"key":"4755_CR26","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.amjms.2016.10.002","volume":"352","author":"SW Keeshin","year":"2016","unstructured":"Keeshin SW, Feinberg J. Endocarditis as a marker for new epidemics of injection drug use. Am J Med Sci. 2016;352:609\u201314.","journal-title":"Am J Med Sci"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-019-4755-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-019-4755-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,7]],"date-time":"2021-01-07T00:12:19Z","timestamp":1609978339000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-019-4755-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,8]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4755"],"URL":"https:\/\/doi.org\/10.1186\/s12879-019-4755-z","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,8]]},"assertion":[{"value":"30 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was reviewed and approved by the ethic committee of the graduate school of medicine, University of Tennessee, approval number 4304, patient consent was waived as this was a retrospective chart review.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"24"}}